150 related articles for article (PubMed ID: 38038938)
1. Assessment of Invadopodium Formation and Gelatin Degradation in Vitro.
Clarke MJ; Battagin S; Coppolino MG
Methods Mol Biol; 2024; 2747():141-149. PubMed ID: 38038938
[TBL] [Abstract][Full Text] [Related]
2. Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells.
Bertier L; Hebbrecht T; Mettepenningen E; De Wit N; Zwaenepoel O; Verhelle A; Gettemans J
Biomed Pharmacother; 2018 Jun; 102():230-241. PubMed ID: 29567535
[TBL] [Abstract][Full Text] [Related]
3. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation.
Oser M; Yamaguchi H; Mader CC; Bravo-Cordero JJ; Arias M; Chen X; Desmarais V; van Rheenen J; Koleske AJ; Condeelis J
J Cell Biol; 2009 Aug; 186(4):571-87. PubMed ID: 19704022
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
[TBL] [Abstract][Full Text] [Related]
5. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes.
Artym VV; Matsumoto K; Mueller SC; Yamada KM
Eur J Cell Biol; 2011; 90(2-3):172-80. PubMed ID: 20656375
[TBL] [Abstract][Full Text] [Related]
6. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
Artym VV; Zhang Y; Seillier-Moiseiwitsch F; Yamada KM; Mueller SC
Cancer Res; 2006 Mar; 66(6):3034-43. PubMed ID: 16540652
[TBL] [Abstract][Full Text] [Related]
7. Matrix Degradation Assay to Measure the Ability of Tumor Cells to Degrade Extracellular Matrix.
Fontana R; Yang J
Methods Mol Biol; 2021; 2294():151-163. PubMed ID: 33742400
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory cortactin nanobodies delineate the role of NTA- and SH3-domain-specific functions during invadopodium formation and cancer cell invasion.
Bertier L; Boucherie C; Zwaenepoel O; Vanloo B; Van Troys M; Van Audenhove I; Gettemans J
FASEB J; 2017 Jun; 31(6):2460-2476. PubMed ID: 28235780
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Invadopodia Formation and Matrix Degradation Activity.
Venghateri JB; Geiger B
Methods Mol Biol; 2023; 2600():185-196. PubMed ID: 36587098
[TBL] [Abstract][Full Text] [Related]
10. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
11. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
Clark ES; Whigham AS; Yarbrough WG; Weaver AM
Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Munc18c and syntaxin4 facilitates invadopodium formation and extracellular matrix invasion of tumor cells.
Brasher MI; Martynowicz DM; Grafinger OR; Hucik A; Shanks-Skinner E; Uniacke J; Coppolino MG
J Biol Chem; 2017 Sep; 292(39):16199-16210. PubMed ID: 28798239
[TBL] [Abstract][Full Text] [Related]
13. Mena
Weidmann MD; Surve CR; Eddy RJ; Chen X; Gertler FB; Sharma VP; Condeelis JS
Sci Rep; 2016 Nov; 6():36142. PubMed ID: 27824079
[TBL] [Abstract][Full Text] [Related]
14. Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells.
Legrand M; Mousson A; Carl P; Rossé L; Justiniano H; Gies JP; Bouvard D; Sick E; Dujardin D; Rondé P
Cell Death Dis; 2023 Mar; 14(3):190. PubMed ID: 36899008
[TBL] [Abstract][Full Text] [Related]
15. MARCKSL1 interacted with F-actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia.
Zhao Y; Xie X; Tian L; Liu F; Sun Y; Lu H; Zhao X; Mao Y
Cancer Med; 2023 Feb; 12(3):3299-3312. PubMed ID: 35894387
[TBL] [Abstract][Full Text] [Related]
16. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
Bowden ET; Barth M; Thomas D; Glazer RI; Mueller SC
Oncogene; 1999 Aug; 18(31):4440-9. PubMed ID: 10442635
[TBL] [Abstract][Full Text] [Related]
17. A new role for cortactin in invadopodia: regulation of protease secretion.
Clark ES; Weaver AM
Eur J Cell Biol; 2008 Sep; 87(8-9):581-90. PubMed ID: 18342393
[TBL] [Abstract][Full Text] [Related]
18. Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion.
Desai B; Ma T; Chellaiah MA
J Biol Chem; 2008 May; 283(20):13856-66. PubMed ID: 18337256
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin.
Yamaguchi H; Lorenz M; Kempiak S; Sarmiento C; Coniglio S; Symons M; Segall J; Eddy R; Miki H; Takenawa T; Condeelis J
J Cell Biol; 2005 Jan; 168(3):441-52. PubMed ID: 15684033
[TBL] [Abstract][Full Text] [Related]
20. A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis.
Twafra S; Sokolik CG; Sneh T; Srikanth KD; Meirson T; Genna A; Chill JH; Gil-Henn H
Oncogene; 2023 Jan; 42(4):278-292. PubMed ID: 36258022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
